New report on neuropsychiatric link with ophthalmologic investigations

NewsGuard 100/100 Score

Regardless of culture, language, era, or individual artist, the arts consistently depict depression using darkness.  Scientific findings now lend empirical support to this representation of depression that everything looks gray when you feel blue.

Researchers at the University of Freiburg in Germany showed previously that people with depression have difficulty detecting black-and-white contrast differences.

Publishing a new report in Biological Psychiatry, these scientists combined neuropsychiatric and ophthalmologic investigations to focus on the response of the retina to varying black-and-white contrasts. Specifically, they measured the pattern electroretinogram, which is like an electrocardiogram (ECG) of the retina of the eye, in patients with depression and healthy individuals. 

They found dramatically lower retinal contrast gain in the depressed patients, regardless of whether or not they were receiving antidepressant medication. There was also a significant correlation between contrast gain and severity of depression, meaning those with the most severe symptoms of depression also had the lowest retinal responses.  The electrophysiological signal of response was sufficiently consistent to distinguish most depressed patients from the healthy subjects.

"These data highlight the profound ways that depression alters one's experience of the world," commented Dr. John Krystal, Editor of Biological Psychiatry.  "The poet William Cowper said that 'variety's the very spice of life', yet when people are depressed, they are less able to perceive contrasts in the visual world.  This loss would seem to make the world a less pleasurable place."

Lead author Dr. Ludger Tebartz van Elst noted that although these findings are strong, they still need to be replicated in further studies.  However, "this method could turn out to be a valuable tool to objectively measure the subjective state of depression, having far-reaching implications for research as well as clinical diagnosis of and therapy for depression."

Source : Biological Psychiatry

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Is psilocybin safe for treating depression and anxiety?